42. 結節性多発動脈炎 [臨床試験数:14,薬物数:27(DrugBank:16),標的遺伝子数:26,標的パスウェイ数:102

Searched query = "Polyarteritis nodosa", "PAN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
9 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2013-004668-71-ES13/10/201605/08/2016A study of treatment for polyarteritis nodosa in childrenAn Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 19.0Level: LLTClassification code 10036026Term: Polyarteritis nodosa of childhoodSystem Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
INN or Proposed INN: CYCLOPHOSPHAMIDE
University College LondonNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
40Phase 3Portugal;Slovenia;Greece;Spain;Turkey;United Kingdom;Italy;Czech Republic;Belgium;Poland;Croatia;Germany;Netherlands;Sweden
2EUCTR2013-004668-71-IT01/08/201614/07/2015A study of treatment for polyarteritis nodosa in childrenAn Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 19.0Level: LLTClassification code 10036026Term: Polyarteritis nodosa of childhoodSystem Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
University College LondonNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
40Phase 3Portugal;Slovenia;Greece;Spain;Turkey;Italy;United Kingdom;Czech Republic;Belgium;Poland;Croatia;Germany;Netherlands;Sweden
3EUCTR2013-004668-71-GB25/09/201425/09/2014A study of treatment for polyarteritis nodosa in childrenAn Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 17.0Level: LLTClassification code 10036026Term: Polyarteritis nodosa of childhoodSystem Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
University College LondonNULLNot RecruitingFemale: yes
Male: yes
40Phase 3Croatia;Portugal;Slovenia;Greece;Spain;Turkey;United Kingdom;Italy;Czech Republic;Belgium;Poland;Germany;Netherlands;Sweden
4NCT00751517September 200811/9/2008Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing VasculitidesCyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides. A Randomized Controlled Trial.Wegener's Granulomatosis;Churg-Strauss Syndrome;Microscopic Polyangiitis;Polyarteritis NodosaDrug: Methotrexate;Drug: CyclophosphamideUniversity of ParmaNULLActive, not recruiting18 Years80 YearsBothPhase 2Italy
5NCT00307671July 200527/3/2006Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsTreatment of Necrotizing Vasculitides for Patients Older Than 65 Years Comparison of Two Strategies Combining Steroids With or Without ImmunosuppressantsVasculitis;Wegener's Granulomatosis;Microscopic Polyangiitis;Churg-Strauss Syndrome;Polyarteritis NodosaDrug: prednisone, methylprednisolone,cyclophosphamides;Drug: Cyclophosphamide, Azathioprine,prednisone,methylprednisolone;Drug: Mycophenolate mofetil,methotrexateAssistance Publique - Hôpitaux de ParisNULLCompleted65 YearsN/ABoth108Phase 4France
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT00006055March 20005/7/2000Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesPurpura, Schoenlein-Henoch;Graft Versus Host Disease;Anemia, Hemolytic, Autoimmune;Rheumatoid Arthritis;Churg-Strauss Syndrome;Hypersensitivity Vasculitis;Wegener's Granulomatosis;Systemic Lupus Erythematosus;Giant Cell Arteritis;Pure Red Cell Aplasia;Juvenile Rheumatoid Arthritis;Polyarteritis Nodosa;Autoimmune Thrombocytopenic Purpura;Takayasu ArteritisDrug: anti-thymocyte globulin;Drug: cyclophosphamide;Drug: cyclosporine;Drug: filgrastim;Drug: methylprednisolone;Drug: prednisone;Procedure: Autologous Peripheral Blood Stem Cell TransplantationFairview University Medical CenterNULLActive, not recruiting1 Year55 YearsBoth10N/AUnited States
7NCT00400075July 199614/11/2006CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis FactorsCHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors a Prospective Randomized Study in 125 PatientsPolyarteritis Nodosa;Microscopic PolyangiitisDrug: azathioprine;Drug: cyclophosphamideHospices Civils de LyonNULLActive, not recruiting15 Years90 YearsBoth124Phase 4Switzerland
8EUCTR2013-004668-71-BE12/04/2017A study of treatment for polyarteritis nodosa in childrenAn Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 19.1Level: LLTClassification code 10036026Term: Polyarteritis nodosa of childhoodSystem Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
INN or Proposed INN: CYCLOPHOSPHAMIDE
INN or Proposed INN: CYCLOPHOSPHAMIDE
University College LondonNULLNAFemale: yes
Male: yes
40Phase 3Portugal;Slovenia;Greece;Spain;Turkey;United Kingdom;Italy;Czech Republic;Belgium;Poland;Croatia;Germany;Netherlands;Sweden
9EUCTR2013-004668-71-PT16/02/2016A study of treatment for polyarteritis nodosa in childrenAn Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 18.1Level: LLTClassification code 10036026Term: Polyarteritis nodosa of childhoodSystem Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
INN or Proposed INN: CYCLOPHOSPHAMIDE
University College LondonNULLNAFemale: yes
Male: yes
40Phase 3Portugal;Slovenia;Greece;Spain;Turkey;United Kingdom;Italy;Czech Republic;Poland;Belgium;Croatia;Germany;Netherlands;Sweden